CytoDyn Inc. CYDY
0.23 USD -0.02 (-9.82%)
As ofNov 18, 2026, 3:59 PM EST
0.225 Day range 0.255
0.18 52-week range 0.40
- YTD
- -19.64%
- 1 year
- -22.41%
News
globenewswire.com CytoDyn Appoints Lauren Wilcoxen, Ph.D., as Chief Operating Officer and Head of Regulatory Affairs VANCOUVER, Washington, Nov. 17, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized…
globenewswire.com CytoDyn Announces $5 Million Private Investment to Advance Leronlimab in Colorectal Cancer and Other Solid Tumors VANCOUVER, Washington, Nov. 12, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized…
